Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology
Free Medical Books

  Prostate Cancer

  Free Subscription


16.01.2012

1 Am J Clin Oncol
2 Am J Pathol
2 BJU Int
1 Cancer
3 Eur Urol
1 Int J Cancer
1 Int J Oncol
8 Int J Radiat Oncol Biol Phys
3 Int J Urol
1 J Clin Oncol
2 J Natl Cancer Inst
1 JAMA
1 N Engl J Med
2 Nat Rev Urol
1 Oncology (Williston Park)
2 Prostate
1 Urol Int


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Oncol

  1. MENDENHALL WM , Hoppe BS, Nichols RC, Henderson RH, et al
    When Is Elective Pelvic Lymph Node Irradiation Indicated in Definitive Radiotherapy for Localized Prostate Cancer?
    Am J Clin Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



    Am J Pathol

  2. WANG H , Jones J, Turner T, He QP, et al
    Clinical and Biological Significance of KISS1 Expression in Prostate Cancer.
    Am J Pathol. 2012.
    PubMed     Text format     Related articles    Abstract available


  3. SHIROTAKE S , Miyajima A, Kosaka T, Tanaka N, et al
    Regulation of Monocyte Chemoattractant Protein-1 Through Angiotensin II Type 1 Receptor in Prostate Cancer.
    Am J Pathol. 2012.
    PubMed     Text format     Related articles    Abstract available



    BJU Int

  4. DENIS L , Joniau S, Bossi A, Baskin-Bey E, et al
    PCA: Prostate Cancer, Patient-Centred Approach or both?
    BJU Int. 2012 Jan 11. doi: 10.1111/j.1464-410X.2011.10859.
    PubMed     Text format     Related articles    Abstract available


  5. DURAND X , Xylinas E, Radulescu C, Haus-Cheymol R, et al
    The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy.
    BJU Int. 2012 Jan 5. doi: 10.1111/j.1464-410X.2011.10682.
    PubMed     Text format     Related articles    Abstract available



    Cancer

  6. COOPERBERG MR , Hilton JF, Carroll PR
    The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy.
    Cancer. 2011;117:5039-46.
    PubMed     Text format     Related articles    Abstract available



    Eur Urol

  7. TODENHOFER T , Schwentner C, Stenzl A
    Personalized Treatment of Prostate Cancer Based on Inherited Variations of Steroid Pathway-Related Genes.
    Eur Urol. 2012.
    PubMed     Text format     Related articles   


  8. SCATTONI V , Raber M, Capitanio U, Abdollah F, et al
    The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic scheme.
    Eur Urol. 2011;60:834-41.
    PubMed     Text format     Related articles    Abstract available


  9. OST P , Lumen N, Goessaert AS, Fonteyne V, et al
    High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results.
    Eur Urol. 2011;60:842-9.
    PubMed     Text format     Related articles    Abstract available



    Int J Cancer

  10. SIMPSON MA , Weigel JA, Weigel PH
    Systemic blockade of the hyaluronan receptor for endocytosis (HARE) prevents lymph node metastasis of prostate cancer.
    Int J Cancer. 2012 Jan 10. doi: 10.1002/ijc.27427.
    PubMed     Text format     Related articles    Abstract available



    Int J Oncol

  11. VANELLA L , Di Giacomo C, Acquaviva R, Santangelo R, et al
    The DDAH/NOS pathway in human prostatic cancer cell lines: antiangiogenic effect of L-NAME.
    Int J Oncol. 2011;39:1303-10.
    PubMed     Text format     Related articles    Abstract available



    Int J Radiat Oncol Biol Phys

  12. VICINI FA , Shah C, Kestin L, Ghilezan M, et al
    Identifying differences between biochemical failure and cure: incidence rates and predictors.
    Int J Radiat Oncol Biol Phys. 2011;81:e369-75.
    PubMed     Text format     Related articles    Abstract available


  13. SHIMIZU S , Osaka Y, Shinohara N, Sazawa A, et al
    Use of implanted markers and interportal adjustment with real-time tracking radiotherapy system to reduce intrafraction prostate motion.
    Int J Radiat Oncol Biol Phys. 2011;81:e393-9.
    PubMed     Text format     Related articles    Abstract available


  14. ZILLI T , Taussky D, Donath D, Le HP, et al
    Urethra-sparing, intraoperative, real-time planned, permanent-seed prostate brachytherapy: toxicity analysis.
    Int J Radiat Oncol Biol Phys. 2011;81:e377-83.
    PubMed     Text format     Related articles    Abstract available


  15. WINKFIELD KM , Chen MH, Dosoretz DE, Salenius SA, et al
    Race and survival following brachytherapy-based treatment for men with localized or locally advanced adenocarcinoma of the prostate.
    Int J Radiat Oncol Biol Phys. 2011;81:e345-50.
    PubMed     Text format     Related articles    Abstract available


  16. KACHIKWU EL , Iwamoto KS, Liao YP, DeMarco JJ, et al
    Radiation enhances regulatory T cell representation.
    Int J Radiat Oncol Biol Phys. 2011;81:1128-35.
    PubMed     Text format     Related articles    Abstract available


  17. BOGGULA R , Jahnke L, Wertz H, Lohr F, et al
    Patient-specific 3D pretreatment and potential 3D online dose verification of Monte Carlo-calculated IMRT prostate treatment plans.
    Int J Radiat Oncol Biol Phys. 2011;81:1168-75.
    PubMed     Text format     Related articles    Abstract available


  18. MUTANGA TF , de Boer HC, van der Wielen GJ, Hoogeman MS, et al
    Margin evaluation in the presence of deformation, rotation, and translation in prostate and entire seminal vesicle irradiation with daily marker-based setup corrections.
    Int J Radiat Oncol Biol Phys. 2011;81:1160-7.
    PubMed     Text format     Related articles    Abstract available


  19. ZAULS AJ , Ashenafi MS, Onicescu G, Clarke HS, et al
    Comparison of intraoperatively built custom linked seeds versus loose seed gun applicator technique using real-time intraoperative planning for permanent prostate brachytherapy.
    Int J Radiat Oncol Biol Phys. 2011;81:1010-6.
    PubMed     Text format     Related articles    Abstract available



    Int J Urol

  20. GAKIYA M , Naka H, Saito S
    Paraneoplastic neurological and hematological syndromes associated with prostate cancer.
    Int J Urol. 2012 Jan 6. doi: 10.1111/j.1442-2042.2011.02949.
    PubMed     Text format     Related articles    Abstract available


  21. CAPITANIO U , Suardi N, Montorsi F, Briganti A, et al
    Editorial Comment to Risk factors for pelvic lymphoceles post-radical prostatectomy.
    Int J Urol. 2011;18:644-5.
    PubMed     Text format     Related articles   


  22. KHODER WY , Trottmann M, Buchner A, Stuber A, et al
    Risk factors for pelvic lymphoceles post-radical prostatectomy.
    Int J Urol. 2011;18:638-43.
    PubMed     Text format     Related articles    Abstract available



    J Clin Oncol

  23. DENNIS ER , Jia X, Mezheritskiy IS, Stephenson RD, et al
    Bone Scan Index: A Quantitative Treatment Response Biomarker for Castration-Resistant Metastatic Prostate Cancer.
    J Clin Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



    J Natl Cancer Inst

  24. HUBER ML , Haynes L, Parker C, Iversen P, et al
    Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer.
    J Natl Cancer Inst. 2012.
    PubMed     Text format     Related articles    Abstract available


  25. ANDRIOLE GL , Crawford ED, Grubb RL 3rd, Buys SS, et al
    Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up.
    J Natl Cancer Inst. 2012.
    PubMed     Text format     Related articles    Abstract available



    JAMA

  26. SLOMSKI A
    Expert panel advocates surveillance for men with low-risk prostate cancer.
    JAMA. 2012;307:133.
    PubMed     Text format     Related articles   



    N Engl J Med

  27. EWING CM , Ray AM, Lange EM, Zuhlke KA, et al
    Germline mutations in HOXB13 and prostate-cancer risk.
    N Engl J Med. 2012;366:141-9.
    PubMed     Text format     Related articles    Abstract available



    Nat Rev Urol

  28. RAZZAK M
    Prostate cancer: Cardiovascular risk and androgen deprivation therapy.
    Nat Rev Urol. 2012 Jan 10. doi: 10.1038/nrurol.2011.
    PubMed     Text format     Related articles   


  29. SFANOS KS , Aloia AL, De Marzo AM, Rein A, et al
    XMRV and prostate cancer-a 'final' perspective.
    Nat Rev Urol. 2012 Jan 10. doi: 10.1038/nrurol.2011.
    PubMed     Text format     Related articles    Abstract available



    Oncology (Williston Park)


  30. Long-term study finds vitamin E supplements raise the risk of prostate cancer.
    Oncology (Williston Park). 2011;25:1236-7.
    PubMed     Text format     Related articles   



    Prostate

  31. GOODMAN M , Ward KC, Osunkoya AO, Datta MW, et al
    Frequency and determinants of disagreement and error in gleason scores: A population-based study of prostate cancer.
    Prostate. 2012 Jan 6. doi: 10.1002/pros.22484.
    PubMed     Text format     Related articles    Abstract available


  32. MILES FL , Tung NS, Aguiar AA, Kurtoglu S, et al
    Increased TGF-beta1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling.
    Prostate. 2012 Jan 6. doi: 10.1002/pros.22482.
    PubMed     Text format     Related articles    Abstract available



    Urol Int

  33. KURODA K , Horiguchi A, Asano T, Tasaki S, et al
    Prediction of Biochemical Recurrence after Radical Prostatectomy Using Peritumoral Lymphatic Vessel Density in Biopsy Specimens in Patients with Localized Prostate Cancer.
    Urol Int. 2012.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: